General MedicationsORALGeneric
GLYBURIDE
GLYBURIDE
Standard Dose
1.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview GLYBURIDE is listed in Drugs@FDA under application 075947 (ANDA).
Marketing status: Discontinued Active ingredient GLYBURIDE Form and strength TABLET;ORAL - 1.5MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2002-11-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview GLYBURIDE is listed in Drugs@FDA under application 075947 (ANDA). Marketing status: Discontinued Active ingredient GLYBURIDE Form and strength TABLET;ORAL - 1.5MG Sponsor ACTAVIS ELIZABETH Submission history Latest submission status date: 2002-11-14 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.